Clinical Study to Evaluate Safety, Immunogenicity of Investigational Flu Vaccine Compared to an Approved Flu Vaccine (QIV) in Children Previously Vaccinated in Trial V118_05

NCT02255409 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

607

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV)
BIOLOGICAL: non-adjuvanted Quadrivalent Influenza Vaccine (QIV)

Sponsor

Seqirus